ТЕРАПИЯ ОСТРЫХ КИШЕЧНЫХ ИНФЕКЦИЙ У ДЕТЕЙ. ДОКАЗАННАЯ ЭФФЕКТИВНОСТЬ (ОБЗОР ЛИТЕРАТУРЫ)


https://doi.org/10.22625/2072-6732-2014-6-1S-9-17

Полный текст:


Аннотация

В статье рассмотрены вопросы этиотропной, патогенетической и симптоматической терапии острых инфекционных диарей у детей. Рекомендации приведены с учетом основных принципов доказательной медицины, включающие суммарные данные рандомизированных клинических испытаний, мета-анализов. Обсуждены новые направления в лечении – возможность применения противорвотных, нтидиарейных, антисекреторных, пробиотических препаратов в педиатрической практике.


Об авторах

С. В. Халиуллина
Казанский государственный медицинский университет, Казань
Россия

докторант кафедры детских инфекций Казанского государственного медицинского университета, к.м.н.; тел.: +7-917-860-92-46



В. А. Анохин
Казанский государственный медицинский университет, Казань
Россия

заведующий кафедрой детских инфекций Казанского государственного медицинского университета, д.м.н., профессор; тел.: 8(843)267-81-00, +7-903-306-33-70



Список литературы

1. Guerrant, R.L. Practice guidelines for the management of infectious diarrhea / R.L.Guerrant [et al.] // Clin Infect Dis. – 2001. – V. 32, № 3. – P. 331–351.

2. Bresee, J.S. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States / J.S. Bresee [et al.] // J Infect Dis. – 2012. – V. 205, № 1. – P. 1374–1381.

3. King, C.К. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy / C.K. King [et al.] // MMWR Recomm Rep. – 2003. – V. 52, № 16 – P. 1–16.

4. Guarino, A. European Society for Paediatric Gastroenterology, Hepatology аnd Nutrition / European Society for PaediatricInfectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe / А.Guarino [et al.] // J Pediatr Gastroenterol Nutr. – 2008. – V. 46, № 5. – P. 619–621.

5. Caprioli, A. Enteropathogens associated with childhood diarrhea in Italy. The Italian Study Group on Gastrointestinal Infections / A. Caprioli [et al.] // Pediatr Infect Dis J. – 1996. – V. 15, № 10. – P. 876–883.

6. De Wit, M.А. Etiology of gastroenteritis in sentinel general practices in the Netherlands / М.А. De Wit [et al.] // Clin Infect Dis. – 2001. – V. 7, № 1. – P. 82–91.

7. Guandalini, S. Lactobacillus GG administered in oral ehydration solution to children with acute diarrhea: a multicenter European trial / S. Guandalini [et al.] // J Pediatr Gastroenterol Nutr . – 2000. – V. 30, № 1. – P. 54–60.

8. Maltezou, H.С. Acute diarrhoea in children treated in an outpatient setting in Athens, Greece / Н.С. Maltezou [et al.] //J Infect. – 2001. – V. 43, № 2. – P. 122–127.

9. Olesen, B. Etiology of diarrhea in young children in Denmark: a case-control study / B.Olesen [et al.] // J Clin Microbiol. – 2005. – V. 43, № 8. – P. 3636–3641.

10. Tompkins, D.S. A study of infectious intestinal disease in England: microbiological findings in cases and controls /D.S.Tompkins [et al.] // Commun Dis Public Health. – 1999. – № 2. – P. 108–113.

11. Годовой отчет референс-центра по мониторингу возбудителей острых кишечных инфекций (РЦКИ) за 2012 год // http://www.epid-oki.ru/cont/analit_pism/Godovoj_otchet_referens-centra_po_monitoringu_vozbuditelej_ostryh_kishechnyh_infekcij.pdf

12. Официальный сайт роспотребнадзора РТ. – //http://16.rospotrebnadzor.ru/

13. Acute diarrhea in adults and children: a global perspective. WGO, February 2012 // http://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf

14. Лечение диареи. Учебное пособие для врачей и других категорий медработников старшего звена. ВОЗ, 2006. –http://www.euro.who.int/__data/assets/pdf_file/0007/130696/9244593181R.pdf

15. World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. Munich, Germany: World Gastroenterology Organisation (WGO); 2008 Mar. 28 p. – http://www.guideline.gov/content.aspx?id=12679&search= salmonellosis

16. Editorial. Oral therapy for acute diarrhea / No authors listed // Lancet. – 1981. – V. 8247, № 2. – P. 615–617.

17. Onwuezobe, I.A. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection / I.A.Onwuezobe, Р.О.Oshun, С.С.Odigwe // Cochrane Database Syst Rev. – 2012. – № 11. – P. 1167.

18. Lee, H.-Y. Oral Cefixime is beneficial in acute uncomplicated Salmonella gastroenteritis in children with mucoid or bloody diarrhea – Do indications of antibiotics therapy need reassessment? / H.-Y.Lee [et al.] // 14th International Congress on Infectious Diseases (ICID) Abstracts. – International Journal of Infectious Diseases. – 2010. – V. 14, № 1. – С. 196–197.

19. Hohmann, E. Approach to the patient with nontyphoidal Salmonella in a stool culture / E. Hohmann // Literature review current through. – 2013. – http://www.uptodate.com/

20. Vukelic, D. Acute Infectious Gastroenterocolitis: Use or Not to Use Antibiotics? / D. Vukelic // 13th International Congress on Infectious Diseases, Abstracts. – International Journal of Infectious Diseases. – 2008. – V. 12, № 1. – P. 25–26.

21. Ternhag, A. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species / A. Ternhag [et al.] // Clin Infect Dis. – 2007. – V. 44, № 5. –P. 696–700.

22. Smith, K.Е. Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota / K.Е. Smith [et al.] // The Pediatric Infectious Disease Journal. – 2012. – V. 31, № 1. – P. 37–41.

23. Tarr, P.I. Shiga-toxin-producing Escherichia coli and haemolytic uremic syndrome / P.I. Tarr, C.A.Gordon, W.L.Chandler // Lancet. – 2005. – V. 365, № 9464. – P. 1073–1086.

24. Molbak, K. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection / K. Molbak, P.S. Mead, P.M. Griffin // JAMA. – 2002. – V. 288, № 8. – С. 1014–1016.

25. Safdar, N. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a metaanalysis / N.Safdar [et al.] // JAMA. – 2002. – V. 288, № 8. – P. 996–1001.

26. Davidson, G. Infectious Diarrhea in Children: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition / G. Davidson [et al.] // Journal of Pediatric Gastroenterology and Nutrition. – 2002. – V. 35, № 2. – P. 143-150.

27. Халиуллина, С.В. Антибиотикорезистентность современных возбудителей внебольничных бактериальных кишечных инфекций у детей / С.В.Халиуллина [и др.] // Практическая медицина. – 2010. – Т. 40, № 1. – С. 85–88.

28. Teran, C.G. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children / C.G. Teran, C.N. Teran-Escalera, P. Villarroel // Int J Infect Dis. – 2009. – V. 13, № 4. – P. 518–523.

29. Rossignol, J. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebocontrolled rial / J.F. Rossignol [et al.] // Lancet. – 2006. – V. 368, № 9530. – P. 124–129.

30. Szajewska, H. Gastrointestinal infections in the pediatric population / H. Szajewska, P. Dziechciarz // Current Opinion in Gastroenterology. – 2010. – V. 26, № 1. – P. 36–44.

31. Uhlen, S. Treatment of acute diarrhea: prescription patterns by private practice pediatricians / S. Uhlen, F. Toursel, F. Gottrand // Arch Pediatr. – 2004. – V. 11, № 8. – P. 903– 907.

32. Practice parameter: the management of acute gastroenteritis in young children. American academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acut Gastroenteritis / No authors listed // Pediatrics. – 1996. – V. 97, № 3. – P. 424–435.

33. Szajewska, H. Meta-analysis: smectite in the treatment of acute infectious diarrhoea in children / H. Szajewska, P. Dziechciarz, J. Mrukowicz // Aliment Pharmacol Ther. – 2006. – V. 23, № 2. – P. 217–227.

34. Mujawar, Q.М. Efficacy of dioctahedral smectite in acute watery diarrhea in Indian children: a randomized clinical trial / Q.М. Mujawar [et al.] // J Trop Pediatr. – 2012. – V. 58, № 1. – P. 63–67.

35. Dupont, C. Peru and Malaysia Diosmectite Study Groups. Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea / C. Dupont [et al.] // Clin Gastroenterol Hepatol. – 2009. – V. 7, № 4. – P. 456–462.

36. Becker, B. Double-blind, randomized evaluation of clinical efficacy and tolerability of an apple pectin–chamomile extract in children with unspecific diarrhea / B. Becker, U. Kuhn, B. Hardewig-Budny // Arzneimittelforschung. – 2006. – V. 56, № 6. – P. 387–393.

37. De la Motte, S. Double-blind comparison of an apple pectin–chamomile extract preparation with placebo in children with diarrhea [in German] / S. De la Motte [et al.] // Arzneimittelforschung. – 1997. – V. 47, № 11. – P. 1247–1249.

38. Watkinson, M. A lack of therapeutic response to kaolin in acute childhood diarrhoea treated with glucose electrolyte solution / M.Watkinson // J Trop Pediatr. – 1982. – V. 28, № 6. – P. 306–307.

39. Zeller, J. The use of actapulgite for the treatment of acute diarrhea in infants and children. Review of pediatric studies [in French] / J. Zeller, P.F. Bougneres // Ann Pediatr (Paris). – 1993. – V. 40, № 4. – P. 276–280.

40. Анохин, В.А. Ацетонемический синдром при острых кишечных инфекциях у детей / В.А. Анохин,

41. С.В. Халиуллина, И.А. Гутор // Детские инфекции. – 2012. – № 1. – С. 6–12.

42. Levine, D. Antiemetics for acute gastroenteritis in children / D.А. Levine // Current Opinion in Pediatrics. – 2009. – V. 21, № 3. – P. 294–298.

43. Kan, K.К. Emetic action of the prostanoid TP receptor agonist, U46619, in Suncus murinus (house musk shrew) /K.К. Kan [et al.] // Eur J Pharmacol. – 2003. – V. 482, № 1–3. – P. 297–304.

44. Pfeil, N. Antiemetic medications in children with presumed infectious gastroenteritis–pharmacoepidemiology in Europe and Northern America / N. Pfeil [et al.] // J Pediatr. – 2008. – V. 153, № 5. – С. 659–662.

45. Zanon, D. Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy / D. Zanon [et al.] // Eur J Pediatr. – 2013. – V. 172, № 3. – P. 361–367.

46. Alhashimi, D. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents / D. Alhashimi, H. Alhashimi, Z. Fedorowicz // Cochrane Database Syst Rev. – 2006. – V. 18, № 4. – P. 005506.

47. Mehra, K. Hypersensitivity to intravenous ondansetron: a case report / K. Mehra [et al.] // J Med Case Reports. –2008. – V. 2. – P. 274.

48. Szajewska, H. Meta-analysis: ondansetron for vomiting in acute gastroenteritis in children / H. Szajewska, D. Gieruszczak-Białek, M. Dylag // Aliment Pharmacol Ther. – 2007. – V. 25, № 4. – P. 393–400.

49. Evidence-based care guideline for prevention and management of acute gastroenteritis (AGE) in children aged 2 months to 18 years. 1999 Nov (revised 2011 Dec 21). NGC:008846. – http://www.guideline.gov/content.aspx?id=35123&search

50. Fedorowicz, Z. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents / Z. Fedorowicz, V.А. Jagannath, В. Carter // Cochrane Database Syst Rev. – 2011. – V. 7. – P. 005506.

51. Levine D. Oral ondansetron decreases vomiting, as well as the need for intravenous fluids and hospital admission, in children with acute gastroenteritis / D. Levine // Evid Based Med. – 2012. – V. 17, № 4. – С. 112–113.

52. Carter, B. Antiemetic treatment for acute gastroenteritis in children: an updated Cochrane systematic review with metaanalysis and mixed treatment comparison in a Bayesian framework / В. Carter, Z. Fedorowicz // BMJ Open. – 2012. – V. 2, № 4. – P. 000622.

53. Freedman, S.В. Oral ondansetron for gastroenteritis in a pediatric emergency department / S.В. Freedman [et al.] //N Engl J Med. – 2006. – V. 354, № 16. – P. 1698-1705.

54. Bruzzese E. Hospital management of children with acute gastroenteritis / Е. Bruzzese, А. Lo Vecchio, А. Guarino // Curr Opin Gastroenterol. – 2013. – V. 29, № 1. – P. 23–30.

55. Al-Ansari, K. Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis / К. Al-Ansari [et al.] // J Pediatr Gastroenterol Nutr. – 2011. – V. 53, № 2. – P. 156–160.

56. Alhashimi, D. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents / D. Alhashimi, H. Al-Hashimi, Z. Fedorowicz // Cochrane Database Syst Rev. – 2009. – № 2. – P. 005506. Review. Update in: Cochrane Database Syst Rev. – 2011. – № 9. – P. 005506.

57. Alhashimi, D. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents / D. Alhashimi, H. Al-Hashimi, Z. Fedorowicz // Cochrane Database Syst Rev. – 2006. – № 4. – C. 005506. Review. Update in: Cochrane Database Syst Rev. – 2009. – № 2. – C. 005506.

58. Запруднов, А.М. Моторно-эвакуаторные нарушения пищеварительного тракта и применение прокинетиков в детском возрасте / А.М. Запруднов // Рус. мед. журнал. Болезни пищеварительной системы. – 2006. – № 8. – C. 22–31.

59. Багненко, С.Ф. Методы фармакологической коррекции двигательно-эвакуаторных нарушений желудка и двенадцатиперстной кишки / С.Ф. Багненко, Е.В. Назаров, М.Ю. Кабанов // Рус. мед. журнал. Болезни органов пищеварения. – 2004. – № 1. – С. 19–23.

60. Roy, P. A comparison of controlled release metoclopramide and domperidone in the treatment of nausea andvomiting / P. Roy, N.Н. Patel, A.J. Miller // British Journal of Clinical Practice. – 1991. – V. 45, № 4. – P. 247–251.

61. Van Eygen, М. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children / М.Van Eygen [et al.] // Postgraduate Medical Journal. – 1979. – V. 55, № 1. – P. 36–39.

62. DeCamp, L.R. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis / L.R. DeCamp [et al.] // Arch Pediatr Adolesc Med. – 2008. – V. 162, № 9. – P. 858–865.

63. Leung, A.К. Acute gastroenteritis in children: role of anti-emetic medication for gastroenteritis-related vomiting /A.К. Leung, W.L. Robson // Paediatr Drugs. – 2007. – V. 9, № 3. – P. 175–184.

64. DuPont, H.L. Systematic review: the epidemiology and clinical features of travellers’ diarrhoea / Н.L. DuPont // Aliment Pharmacol Ther. – 2009. – V. 30, № 3. – V. 187–196.

65. Wingate, D. Guidelines for adults on self-medication for he treatment of acute diarrhea / D. Wingate [et al.] // Aliment Pharmacol Ther. – 2001. – V. 15, № 6. – P. 773–782.

66. Nelson, J.М. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites / J.M. Nelson [et al.] // Clin Infect Dis. – 2011. – V. 52, № 9. – P. 1130–1132.

67. Dalby-Payne, J.R. Gastroenteritis in children / J.R. Dalby-Payne, Е.J. Elliott // Clin Evid (Online). – 2009.

68. Li, S.Т. Loperamide therapy for acute diarrhea in children: Systematic review and meta-analysis / S.Т. Li, D.С. Grossman, P. Cummings // PLoS Med. – 2007. – V. 4, № 3. – P. 495–505.

69. Eberlin, M. A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril / M. Eberlin, T. Mück, M.С. Michel // Front Pharmacol. – 2012. – № 3. – P. 93.

70. Salazar-Lindo, E. Racecadotril in the treatment of acute watery diarrhea in children / E. Salazar-Lindo [et al.] // N Engl J Med. – 2000. – V. 343, № 7. – С. 463–467.

71. Faure C. Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children / C. Faure // Int J Pediatr. – 2013. – V. 27, № 5.– 612403.

72. Tormo, R. Acute infectious diarrhoea in children: new insights in antisecretory treatment with racecadotril / R.Tormo [et al.] // Acta Paediatr. – 2008. – V. 97, № 8. – P. 1008–1015.

73. Cezard, J.Р. Efficacy and tolerability of racecadotril in acute diarrhea in children / J.Р.Cezard [et al.] // Gastroenterology. – 2001. – V. 120, № 4. – P. 799–805.

74. Cojocaru, B. Effect of racecadotril in the management of acute diarrhea in infants and children [in French] / J. Cezard [et al.] // Arch Pediatr. – 2002. – V. 9, № 8. – P. 774–779.

75. Lehert, P. Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis / P. Lehert, G. Chéron, G.А. Calatayud // Dig Liver Dis. – 2011. – V. 43, № 9. – P. 707–713.

76. Rautenberg, T.А. Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model / Т.А. Rautenberg [et al.] // Clinicoecon Outcomes Res. – 2012. – № 4. – P. 109–116.

77. Gallelli, L. Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes / L. Gallelli, M. Colosimo, G.А. Tolotta // Eur J Clin Pharmacol. – 2010. – V. 66, № 2. – P. 137–144.

78. Guarino, A. Which place for bismuth subsalicylate in the treatment of enteric infections? / А. Guarino, Е. Bruzzese //Acta Paediatr. – 2001. – V. 90, № 6. – P. 601–604.

79. Connor, B.А. Prevention and treatment of acute traveler's diarrhea / B.А. Connor, B. Landzberg // Infect Med. –2004. – V. 21, № 1. – P. 18–19.

80. Gottlieb, T. Diarrhoea in adults (acute) / T. Gottlieb, C.S. Heather // Clin Evid (Online). – 2011. – V. 27, № 11.– 0901.

81. Steffen, R. Travelers’ diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy / R. Steffen [et al.] // J Infect Dis. – 1988. – V. 157, № 5. – P. 1008–1013.

82. Johnson, P.С. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers’ diarrhea / P.С. Johnson [et al.] // JAMA. – 1986. – V. 255, № 6. – P. 757–760.

83. DuPont, H.L. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea / H.L. DuPont [et al.] // Am J Med. – 1990. – V. 88, № 6А. – P. 15–19.

84. Chowdhury, H.R. The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhea / H.R. Chowdhury [et al.] // Acta Paediatr. – 2001. – V. 90, № 6. – P. 605–610.

85. Реализация новых рекомендаций по клиническому ведению диареи : pуководство для лиц, ответственных за принятие решений и программных менеджеров. – ВОЗ, 2012. – www.euro.who.int/__data/assets/pdf_file/0007/.../9244594218R.pdf.

86. Pieścik-Lech, M. Review Article: The Management of Acute Gastroenteritis in Children / M. Pieścik-Lech [et al.] //Aliment Pharmacol Ther. – 2013. – V. 37, № 3. – P. 289–303.

87. Patro, B. Meta-analysis: zinc supplementation for acute gastroenteritis in children / B. Patro, D. Golicki, H. Szajewska // Aliment Pharmacol Ther. – 2008. – V. 28, № 6. – P. 713–723.

88. Patel, A. Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic review / A. Patel [et al.] // PLoS. One. – 2010. – V. 5, № 4. – P. 10386.

89. Lazzerini, M. Oral zinc for treating diarrhoea in children / M. Lazzerini, L. Ronfani // CochraneDatabase Syst Rev. – 2013. – № 6. – P. 005436.

90. Patro, B. Oral zinc for the treatment of acute gastroenteritis in Polish children: a randomized, double-blind, placebocontrolled trial / B. Patro, H. Szyma ski, H. Szajewska // J Pediatr. – 2010. – V. 157, № 6. – P. 984–988.

91. Abrams, S. Zinc deficiency and supplementation in children and adolescents / S. Abrams. – http://www.uptodate. com/contents/zinc-deficiency-and-supplementation-in-children- and-adolescents/contributors.

92. Canani, R.В. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes / R.В. Canani [et al.]// J Infect Dis. – 2005. – V.191, № 7. – P. 1072–1077.

93. Crane, J.K. Effect of zinc in enteropathogenic Escherichia coli infection / J.K. Crane [et al.] // Infect Immun. – 2007. – V. 75, № 12. – P. 5974–5984.

94. Вrown, K.Н. Zinc fortification of cereal flours: current recommendations and research needs / K.Н. Вrown, K.М. Hambidge, P. Ranum // Food Nutr Bull. – 2010. – V. 31, № 1. – P. 62–74.

95. Allen, S.J. Probiotics for treating acute infectious diarrhoea (Review) / S.J. Allen [et al.] // Cochrane Database Syst Rev. – 2010. – V. 10, № 11. – P. 003048.

96. Weizman, Z. Probiotics Use in Childhood Acute Diarrhea: A Web-based Survey / Z.Weizman // Journal of Clinical Gastroenterology. – 2011. – V. 45, № 5. – P. 426–428.

97. Best evidence statement (BESt). Use of Lactobacillus rhamnosus GG in children with acute gastroenteritis. – http://www. guidelines.gov/content.aspx?id=33576&search=probiotics

98. Szajewska, H. Advances and limitations of evidencebased medicine – impact for probiotics / H. Szajewska // Ann Nutr Metab. – 2010. – № 57. – P. 6–9.

99. Szajewska, H. Probiotics in the Treatment and Prevention of Acute Infectious Diarrhea in Infants and Children: A Systematic Review of Published Randomized, Double-Blind, Placebo- Controlled Trials / H. Szajewska, J.Z. Mrukowicz // Journal of Pediatric Gastroenterology and Nutrition. – 2001. – V. 33, № 2. – P. 17–25.

100. Riaz, M. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial / M. Riaz [et al.] // Indian J Pediatr. – 2012. – V. 79, № 4. – P. 478–482.

101. Corrêa, N.В. Treatment of acute diarrhea with Saccharomyces boulardii in infants / N.В. Corrêa [et al.] // J Pediatr Gastroenterol Nutr. – 2011. – V. 53, № 5. – P. 497–501.

102. Szajewska, H. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials / H. Szajewska, A. Skórka // Aliment Pharmacol Ther. – 2009. – V. 30, № 9. – P. 960–961.

103. Dinleyici, E.С. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea / E.С. Dinleyici [et al.] // Expert Opin BiolTher. – 2012. – V. 12, № 4. – P. 395–410.

104. Francavilla, R. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea – a double-blind study / R. Francavilla [et al.] // Aliment Pharmacol Ther. – 2012. – V. 36, № 4. – P. 363–369.


Дополнительные файлы

Для цитирования: Халиуллина С.В., Анохин В.А. ТЕРАПИЯ ОСТРЫХ КИШЕЧНЫХ ИНФЕКЦИЙ У ДЕТЕЙ. ДОКАЗАННАЯ ЭФФЕКТИВНОСТЬ (ОБЗОР ЛИТЕРАТУРЫ). Журнал инфектологии. 2014;6(1S):9-17. https://doi.org/10.22625/2072-6732-2014-6-1S-9-17

For citation: Khaliullina S.V., Anokhin V.A. Therapy of Acute Intestinal Infections in Children: Proven Efficiency. Journal Infectology. 2014;6(1S):9-17. (In Russ.) https://doi.org/10.22625/2072-6732-2014-6-1S-9-17

Просмотров: 341

Обратные ссылки

  • Обратные ссылки не определены.


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)
ISSN 2499-9865 (Online)